Myoclonin1/EFHC1 disease mechanisms in JME

Thierry Grisar, Joseph Loturco, Andrea Daga, Antonio V. Delgado-Escueta

Research output: Contribution to journalArticle

Abstract

Myoclonin1/EFHC1 mutations cause 9% of juvenile myoclonic epilepsy (JME) by impairing apoptosis in neurons/synapses where R type voltage dependent calcium channel function is altered, imbuing susceptibility to myoclonic and grand mal seizures. By disrupting mitotic spindle assembly and radial migration of neuroblasts, mutations could produce abnormal intracortical architecture upon which epileptogenesis is established. For an expanded treatment of this topic see Jasper's Basic Mechanisms of the Epilepsies, Fourth Edition (Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds) published by Oxford University Press (available on the National Library of Medicine Bookshelf [NCBI] at).

Original languageEnglish
Pages (from-to)74
Number of pages1
JournalEpilepsia
Volume51
Issue numberSUPPL. 5
DOIs
Publication statusPublished - Dec 2010

Keywords

  • Apoptosis
  • Brain development
  • Calcium homeostasis
  • Cell division
  • Epileptogenesis
  • Juvenile myoclonic epilepsy
  • Migration
  • Seizures

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Fingerprint Dive into the research topics of 'Myoclonin1/EFHC1 disease mechanisms in JME'. Together they form a unique fingerprint.

  • Cite this

    Grisar, T., Loturco, J., Daga, A., & Delgado-Escueta, A. V. (2010). Myoclonin1/EFHC1 disease mechanisms in JME. Epilepsia, 51(SUPPL. 5), 74. https://doi.org/10.1111/j.1528-1167.2010.02860.x